Verve Therapeutics, Inc.: SCHEDULE 13G/A filed Aug 14, 2025

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2025

Accession number

0000921895-25-002286

Filer

Verve Therapeutics, Inc. (CIK 1840574)